Vol 10, Supp. B (2019)
Case report
Published online: 2019-10-02

open access

Page views 981
Article views/downloads 1065
Get Citation

Connect on Social Media

Connect on Social Media

Long-term efficacy of azacitidine in a patient with acute myeloid leukemia with myelodysplastic-related changes

Marcin Wójtowicz1

Abstract

Azacitidine is a hypomethylating agent, commonly used in treatment of acute myeloid leukemia with 20–30% bone marrow blasts. We present a case of a long-term efficacy of this drug used in the patient for 36 months.

Article available in PDF format

View PDF (Polish) Download PDF file



Hematology in Clinical Practice